Related Experiment Video

Updated: May 16, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Models of crk adaptor proteins in cancer

Emily S Bell1, Morag Park

  • 1McGill University, Montréal, QC, Canada.

Genes & Cancer
|December 11, 2012
PubMed

Insights

Crk proteins, lacking catalytic activity, are crucial adaptors in cancer progression. Understanding their signaling mechanisms is key for developing targeted cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Crk proteins (CrkI, CrkII, CrkL) are adaptor proteins involved in various signaling pathways.
  • They lack catalytic activity but link tyrosine kinase and integrin signals to downstream effectors.
  • Crk proteins are implicated in the malignancy of numerous human cancers.

Purpose of the Study:

  • To elucidate the poorly understood in vivo mechanisms of Crk proteins in cancer progression.
  • To investigate the role of Crk signaling in diverse cellular processes and malignancy.
  • To provide a foundation for therapeutic targeting of Crk-driven cancers.

Main Methods:

  • Review of recent advances in Crk protein structural organization and kinase regulation.
  • Analysis of Crk overexpression frequency in human cancers.
  • Emphasis on the need for in vivo models to study Crk function.

Main Results:

  • Crk proteins act as crucial adaptors, integrating upstream signals.
  • Crk signaling is pleiotropic, contributing to cancer malignancy across different cell types.
  • Crk overexpression is frequent in human cancers, highlighting its oncogenic potential.

Conclusions:

  • Crk proteins are significant oncogenic drivers in human cancers.
  • Further in vivo studies are essential to fully understand Crk's role in cancer progression.
  • Targeting Crk signaling pathways may offer novel therapeutic strategies for cancer treatment.
Keywords:
Crk adaptor proteinsmouse modelsregulationsignal transduction

More Related Videos

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...